Whatsapp

Cefnep 250mg Injection is effective against various types of bacteria and works by inhibiting their growth This medication helps to alleviate your symptoms and address the underlying infection It is administered through intravenous infusion or directly into a vein or muscle under the supervision of a healthcare professional Your doctor will determine the appropriate dosage for you Be sure to use this medication regularly and adhere to the schedule prescribed by your doctor It is important not to miss any doses and to complete the full course of treatment even if you start feeling better Discontinuing the medication prematurely may result in the infection returning or worsening The commonly observed side effects of this medication include rash and diarrhea Some individuals may experience temporary redness or discomfort at the injection site These side effects are typically mild but it is essential to inform your doctor if they are bothersome or persistent beyond a few days Prior to using this medication inform your doctor if you have any allergies to antibiotics or if you have liver or kidney issues Additionally inform your healthcare team about all other medications you are currently taking as they may interact with or be influenced by this medication Pregnant and breastfeeding mothers should consult their doctor before using this medication

halth-assessment-tools

Available in 2 variations

thumbnail.svg

Cefnep 250mg Injection

Cefnep 250mg Injection

Ceftazidime (250mg)

vial of 2 ml Injection

thumbnail.svg

Cefnep 1gm Injection

Cefnep 1gm Injection

Ceftazidime (1gm)

vial of 2 ml Injection

Written By:

about-us.jpg

Published At: Dec 10, 2024

Updated At: Dec 26, 2024

Reviewed By:

about-us.jpg

Published At: Dec 10, 2024

Updated At: Dec 26, 2024

Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.